The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Open accessAbstract
BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is an important risk factor for hepatocellular carcinoma (HCC). Despite effective antiviral therapies, the risk for HCC is decreased but not eliminated after a sustained virologic response (SVR) to direct-acting antiviral (DAA) agents, and the risk is higher in patients with advanced fibrosis. We investigated HCV-induced epigenetic alterations that might affect risk for HCC after DAA treatment in patients and mice with humanized livers. METHODS: We performed genome-wide ChIPmentation-based ChIP-Seq and RNA-seq analyses of liver tissues from 6 patients without HCV infection (controls), 18 patients with chronic HCV infection, 8 patients with chronic HCV infection cured by DAA treatment, 13 patients with chronic HCV infection cured by interferon therapy, 4 patients with chronic hepatitis B virus infection, and 7 patients with nonalcoholic steatohepatitis in Europe and Japan. HCV-induced epigenetic modifications were mapped by comparative analyses with modifications associated with other liver disease etiologies. uPA/SCID mice were engrafted with human hepatocytes to create mice with humanized livers and given injections of HCV-infected serum samples from patients; mice were given DAAs to eradicate the virus. Pathways associated with HCC risk were identified by integrative pathway analyses and validated in analyses of paired HCC tissues from 8 patients with an SVR to DAA treatment of HCV infection. RESULTS: We found chronic HCV infection to induce specific genome-wide changes in H3K27ac, which correlated with changes in expression of mRNAs and proteins. These changes persisted after an SVR to DAAs or interferon-based therapies. Integrative pathway analyses of liver tissues from patients and mice with humanized livers demonstrated that HCV-induced epigenetic alterations were associated with liver cancer risk. Computational analyses associated increased expression of SPHK1 with HCC risk. We validated these findings in an independent cohort of patients with HCV-related cirrhosis (n = 216), a subset of which (n = 21) achieved viral clearance. CONCLUSIONS: In an analysis of liver tissues from patients with and without an SVR to DAA therapy, we identified epigenetic and gene expression alterations associated with risk for HCC. These alterations might be targeted to prevent liver cancer in patients treated for HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Li, H. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr509 · Cited by 6,486
Modification of Enhancer Chromatin: What, How, and Why?
Calo, E., & Wysocka, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.038 · Cited by 1,457
Gene expression in fixed tissues and outcome in hepatocellular carcinoma
Hoshida, Y., Villanueva, A., Kobayashi, M., Peix, J., Chiang, D. Y., Camargo, A., Gupta, S., Moore, J., Wrobel, M. J., Lerner, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804525 · Cited by 1,286
Self-citationMethylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark
Ruthenburg, A. J., Allis, C. D., & Wysocka, J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.014 · Cited by 1,147
Targeting the cancer epigenome for therapy
Jones, P. A., Issa, J.-P. J., & Baylin, S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.93 · Cited by 1,128
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115 · cited 1×
“28 Indeed, latent Epstein-Barr infection triggered persistent epigenetic reprogramming, possibly resulting in the establishment of immortal growth and cancer, whereas transient hyperglycemia resulted in persistent enrichment of H3K4me1 on the p65 gene promoter and subsequently in oxidative stress…”
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659 · cited 2×
“2 However, we point out that this mechanism is not exclusive, and many other factors most likely contribute to hepatocarcinogenesis after cure.”
Self-citationGENCODE: producing a reference annotation for ENCODE
Harrow, J., Denoeud, F., Frankish, A., Reymond, A., Chen, C.-K., Chrast, J., Lagarde, J., Gilbert, J. G., Storey, R., Swarbreck, D., et al. (2006) · Genome Biology · doi:10.1186/gb-2006-7-s1-s4 · Cited by 648
ChIPmentation: fast, robust, low-input ChIP-seq for histones and transcription factors
Schmidl, C., Rendeiro, A. F., Sheffield, N. C., & Bock, C. (2015) · Nature Methods · doi:10.1038/nmeth.3542 · Cited by 509
Self-citationEl‐Serag, H. B., Kanwal, F., Richardson, P., & Kramer, J. (2016) · Hepatology · doi:10.1002/hep.28535 · Cited by 411
van der Meer, A. J., Feld, J. J., Hofer, H., Almasio, P. L., Calvaruso, V., Fernández-Rodríguez, C. M., Aleman, S., Ganne-Carrié, N., D’Ambrosio, R., Pol, S., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.017 · Cited by 274
Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis
Hoshida, Y., Villanueva, A., Sangiovanni, A., Sole, M., Hur, C., Andersson, K. L., Chung, R. T., Gould, J., Kojima, K., Gupta, S., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.021 · Cited by 228
Self-citationNakagawa, S., Wei, L., Song, W. M., Higashi, T., Ghoshal, S., Kim, R. S., Bian, C. B., Yamada, S., Sun, X., Venkatesh, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.004 · Cited by 205
Self-citationEpigenetics and Liver Fibrosis
Morán‐Salvador, E., & Mann, J. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.04.007 · Cited by 149
Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice
Tateno, C., Kawase, Y., Tobita, Y., Hamamura, S., Ohshita, H., Yokomichi, H., Sanada, H., Kakuni, M., Shiota, A., Kojima, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142145 · Cited by 148
Cai, M.-Y., Hou, J.-H., Rao, H., Luo, R.-Z., Li, M., Pei, X., Lin, M. C. M., Guan, X., Kung, H., Zeng, Y.-X., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00103 · Cited by 136
Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4–MMP1 axis
Kim, E., Kim, D., Lee, J., Yoe, J., Park, J., Kim, C., Jeong, D., Kim, S., & Lee, Y. (2017) · Hepatology · doi:10.1002/hep.29738 · Cited by 118
Hepatitis Virus Infection Affects DNA Methylation in Mice With Humanized Livers
Okamoto, Y., Shinjo, K., Shimizu, Y., Sano, T., Yamao, K., Gao, W., Fujii, M., Osada, H., Sekido, Y., Murakami, S., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.056 · Cited by 113
Epigenetic reprogramming in liver fibrosis and cancer
Wilson, C. L., Mann, D. A., & Borthwick, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.011 · Cited by 106
Hatoum, D., Haddadi, N., Lin, Y., Nassif, N. T., & McGowan, E. M. (2017) · Oncotarget · doi:10.18632/oncotarget.16370 · Cited by 105
Epstein–Barr virus: a master epigenetic manipulator
Scott, R. S. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.07.017 · Cited by 92
King, L. Y., Canasto‐Chibuque, C., Johnson, K. B., Yip, S. H., Chen, X., Kojima, K., Deshmukh, M., Venkatesh, A., Tan, P. S., Sun, X., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307862 · Cited by 80
Self-citationRenne, N. V., Suarez, A. A. R., Duong, F. H. T., Gondeau, C., Calabrese, D., Fontaine, N., Ababsa, A., Bandiera, S., Croonenborghs, T., Pochet, N. L. M. M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312270 · Cited by 76
Self-citationBoldanova, T., Suslov, A., Heim, M. H., & Necşulea, A. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607006 · Cited by 75
Self-citationSphingosine kinase and sphingosine-1-phosphate in liver pathobiology
Rohrbach, T. D., Maceyka, M. W., & Spiegel, S. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1337706 · Cited by 72
Bae, W. K., Kang, K., Yu, J. H., Yoo, K. H., Factor, V. M., Kaji, K., Matter, M. S., Thorgeirsson, S. S., & Hennighausen, L. G. (2014) · The FASEB Journal · doi:10.1096/fj.14-261537 · Cited by 66
Richtig, G., Aigelsreiter, A., Schwarzenbacher, D., Ress, A. L., Adiprasito, J. B., Stiegelbauer, V., Höefler, G., Schauer, S., Kiesslich, T., Kornprat, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187814 · Cited by 62
Hayashi, A., Yamauchi, N., Shibahara, J., Kimurâ, H., Morikawa, T., Ishikawa, S., Nagae, G., Nishi, A., Sakamoto, Y., Kokudo, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091330 · Cited by 42
Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma
Cai, H., Xie, X., Ji, L., Ruan, X., & Zheng, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.5732 · Cited by 40
Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice
Chen, J., Qi, Y., Zhao, Y., Kaczorowski, D. C., Couttas, T. A., Coleman, P. R., Don, A. S., Bertolino, P., Gamble, J. R., Vadas, M. A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24583 · Cited by 34
Cited by
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“Several studies have shown that chronic HCV infection results in persistent epigenetic and transcriptional changes associated with the stage of fibrosis and HCC risk [185,186], suggesting that viral cure only partially eliminates the virus-induced pro-fibrogenic and carcinogenic drivers particularly in advanced fibros…”
BackgroundSelf-citationMetabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
Roehlen, N., Saviano, A., El Saghire, H., Crouchet, E., Nehme, Z., Del Zompo, F., Jühling, F., Oudot, M. A., Durand, S. C., Duong, F. H. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj4221 · Cited by 54
Self-citationSingle-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis
Cui, A., Li, B., Wallace, M. S., Gonye, A. L. K., Oetheimer, C., Patel, H., Tonnerre, P., Holmes, J. A., Lieb, D., Yao, B. S., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.02.040 · Cited by 46
Metadata
- Authors
- Hamdane, N., Jühling, F., Crouchet, E., El Saghire, H., Thumann, C., Oudot, M. A., Bandiera, S., Saviano, A., Ponsolles, C., Roca Suarez, A. A., Li, S., Fujiwara, N., Ono, A., Davidson, I., Bardeesy, N., Schmidl, C., Bock, C., Schuster, C., Lupberger, J., Habersetzer, F., Doffoël, M., Piardi, T., Sommacale, D., Imamura, M., Uchida, T., Ohdan, H., Aikata, H., Chayama, K., Boldanova, T., Pessaux, P., Fuchs, B. C., Hoshida, Y., Zeisel, M. B., Duong, F. H. T., & Baumert, T. F.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 156
- Issue
- 8
- Pages
- 2313-2329.e7
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2918873588
- Cited by
- 275
- References
- 40
- FWCI
- 21.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.